- Home
- PRGO vs SSSS Comparison
PRGO vs SSSS Comparison
Compare PRGO & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- SSSS
- Stock Information
- Founded
- PRGO 1887
- SSSS 2010
- Country
- PRGO Ireland
- SSSS United States
- Employees
- PRGO 9140
- SSSS N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- SSSS Finance: Consumer Services
- Sector
- PRGO Health Care
- SSSS Finance
- Exchange
- PRGO Nasdaq
- SSSS Nasdaq
- Market Cap
- PRGO 3.5B
- SSSS 143.5M
- IPO Year
- PRGO 1991
- SSSS N/A
- Fundamental
- Price
- PRGO $25.76
- SSSS $5.83
- Analyst Decision
- PRGO Buy
- SSSS Buy
- Analyst Count
- PRGO 4
- SSSS 2
- Target Price
- PRGO $37.00
- SSSS $6.00
- AVG Volume (30 Days)
- PRGO 1.3M
- SSSS 245.8K
- Earning Date
- PRGO 11-06-2024
- SSSS 11-07-2024
- Dividend Yield
- PRGO 4.29%
- SSSS N/A
- EPS Growth
- PRGO N/A
- SSSS N/A
- EPS
- PRGO N/A
- SSSS N/A
- Revenue
- PRGO $4,392,000,000.00
- SSSS $5,903,895.00
- Revenue This Year
- PRGO N/A
- SSSS N/A
- Revenue Next Year
- PRGO $4.51
- SSSS $6.05
- P/E Ratio
- PRGO N/A
- SSSS N/A
- Revenue Growth
- PRGO N/A
- SSSS 5.43
- 52 Week Low
- PRGO $23.89
- SSSS $3.32
- 52 Week High
- PRGO $34.60
- SSSS $6.65
- Technical
- Relative Strength Index (RSI)
- PRGO 36.42
- SSSS 55.63
- Support Level
- PRGO $25.16
- SSSS $5.51
- Resistance Level
- PRGO $28.62
- SSSS $6.65
- Average True Range (ATR)
- PRGO 0.66
- SSSS 0.39
- MACD
- PRGO -0.35
- SSSS -0.06
- Stochastic Oscillator
- PRGO 15.79
- SSSS 39.71
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.